A rare case of synchronous mucosa-associated lymphoid tissue (MALT) lymphoma involving bilateral breasts and subcutaneous tissues

Breast mucosa-associated lymphoid tissue lymphoma: A case report and literature review

“…Tacrolimus and azathioprine >6 mo >6 mo Kim et al, 2015 [32] 55 NA Both breasts Total mastectomy of both breasts >9 mo >9 mo Hissourouiii et al, 2016 [33] 40 NA Left breast Lumpectomy + RT >3 mo >3 mo Amalia et al, 2017 [34] 67 SS Both breasts NA NA NA Belfeki et al, 2019 [35] 65 SS Right breast NA NA NA Ludmir et al, 2019 [36] NA NA Both breasts Observation NA 67.2 mo Ludmir et al, 2019 [36] NA NA Both breasts Observation NA 22.6 mo Ludmir et al, 2019 [36] NA NA Right breast Single-agent rituximab NA 1.6 mo Ludmir et al, 2019 [36] NA NA Left breast RT NA 47.8 mo Ludmir et al, 2019 [36] NA NA Right breast RT NA 43.6 mo Ludmir et al, 2019 [36] NA NA Right breast RT NA 82.6 mo Ludmir et al, 2019 [36] NA NA Left breast RT NA 34.3 mo Ludmir et al, 2019 [36] NA NA Left breast RT NA 73.5 mo Ludmir et al, 2019 [36] NA NA Left breast RT NA 74.0 mo Ludmir et al, 2019 [36] NA NA Right breast RT NA 7.3 mo Ludmir et al, 2019 [36] NA NA Left breast Lumpectomy + RT NA 18.8 mo Ingravallo et al, 2020 [37] 57 SS Right breast NA NA NA Anendaga et al, 2022 [38] 63 NA Right breast Systemic chemotherapy with rituximab*4 >2 yr >2 yr Hussain Dalal et al, 2023 [39] 70 SS and Stage 1 renal cell carcinoma Left breast Lumpectomy NA NA CHOP = cyclophosphamide, doxorubicin, vincristine and prednisone, MALT = mucosa-associated lymphoid tissue, NA = not available, OS = overall survival, PFS = progression-free survival, RT = radiation therapy, SS = Sjogren syndrome.…”